Prospective evaluation of serum glial fibrillary acidic protein (GFAP) as a diagnostic marker for glioblastoma.

导出原文传递

翻译打印收藏纠错

第一作者： Julia,Tichy

第一单位： Department of Neurology, Goethe-University, Frankfurt am Main, Germany. julia.tichy@kgu.de.

作者： Julia,Tichy ^[1] ; Sabrina,Spechtmeyer ^[2] ; Michel,Mittelbronn ^[3] ; Elke,Hattingen ^[4] ; Johannes,Rieger ^[5] ; Christian,Senft ^[6] ; Christian,Foerch ^[7]

作者单位： Department of Neurology, Goethe-University, Frankfurt am Main, Germany. julia.tichy@kgu.de. ^[1] Dr. Senckenberg Institute of Neurooncology, Goethe-University, Frankfurt am Main, Germany. julia.tichy@kgu.de. ^[2] Neurological Institute (Edinger Institute), Goethe-University, Frankfurt am Main, Germany. julia.tichy@kgu.de. ^[3] Dr. Senckenberg Institute of Neurooncology, Department of Neurology, Goethe-University Hospital Frankfurt, Schleusenweg 2-16, 60528, Frankfurt, Germany. julia.tichy@kgu.de. ^[4] Department of Neurology, Goethe-University, Frankfurt am Main, Germany. ^[5] Neurological Institute (Edinger Institute), Goethe-University, Frankfurt am Main, Germany. ^[6] German Cancer Consortium (DKTK), Heidelberg, Germany. ^[7] German Cancer Research Center (DKFZ), Heidelberg, Germany. ^[8] Institute of Neuroradiology, Goethe-University, Frankfurt am Main, Germany. ^[9] Dr. Senckenberg Institute of Neurooncology, Goethe-University, Frankfurt am Main, Germany. ^[10] Department of Neurosurgery, Goethe-University, Frankfurt am Main, Germany. ^[11]

关键词 Biomarker Diagnostic marker GFAP Glioblastoma Serum